9.BETA.,10.ALPHA.-PREGNA-4,6,8(14)-TRIENE-3,20-DIONE
UNII LJ088CWL1E

Substance Identification & Data

This profile provides standardized clinical and technical data for 9.beta.,10.alpha.-pregna-4,6,8(14)-triene-3,20-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LJ088CWL1E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23035-53-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LJ088CWL1E

CAS Registry Number

23035-53-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

9.BETA.,10.ALPHA.-PREGNA-4,6,8(14)-TRIENE-3,20-DIONE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H26O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HMDYHHQZKIYROJ-CWJKEVGVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

71587052

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12([C@H](CCC1=C3[C@]([C@]4(C(C=C3)=CC(CC4)=O)C)(CC2)[H])C(=O)C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 9.beta.,10.alpha.-pregna-4,6,8(14)-triene-3,20-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.